Page 1 of 12
Type 2 Diabetes Pharmacotherapy: Knowledge Check
Test your knowledge with these 10 questions! 🤩
You can prepare by reading our
"Type 2 Diabetes Pharmacotherapy Review"
found in Pyrls!
1.
According to the 2023 ADA Standards of Care in Diabetes, which one of the following drug classes is considered to have intermediate glucose-lowering efficacy?
*
1. According to the 2023 ADA Standards of Care in Diabetes, which one of the following drug classes is considered to have intermediate glucose-lowering efficacy?
A
Insulin
B
GLP-1 receptor agonist
C
DPP-4 inhibitor
D
SGLT2 inhibitor
Next